Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsSynthesized compounds were evaluated for their in vitro anticancer activity against various human cancer cell lines, including breast and prostate.
[Bioorganic Chemistry]
6445218 Y9WP36VB items 1 apa 0 default asc 1 165281 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-201d6c5f3194681f353c6aa091c94316%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22Y9WP36VB%22%2C%22library%22%3A%7B%22id%22%3A6445218%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Parmar%20et%20al.%22%2C%22parsedDate%22%3A%222021-10-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EParmar%2C%20D.%20R.%2C%20Soni%2C%20J.%20Y.%2C%20Guduru%2C%20R.%2C%20Rayani%2C%20R.%20H.%2C%20Kusurkar%2C%20R.%20V.%2C%20Vala%2C%20A.%20G.%2C%20Talukdar%2C%20S.%20N.%2C%20Eissa%2C%20I.%20H.%2C%20Metwaly%2C%20A.%20M.%2C%20Khalil%2C%20A.%2C%20Zunjar%2C%20V.%2C%20%26amp%3B%20Battula%2C%20S.%20%282021%29.%20Discovery%20of%20new%20anticancer%20thiourea-azetidine%20hybrids%3A%20design%2C%20synthesis%2C%20in%20vitro%20antiproliferative%2C%20SAR%2C%20in%20silico%20molecular%20docking%20against%20VEGFR-2%2C%20ADMET%2C%20toxicity%2C%20and%20DFT%20studies.%20%3Ci%3EBioorganic%20Chemistry%3C%5C%2Fi%3E%2C%20%3Ci%3E115%3C%5C%2Fi%3E%2C%20105206.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.bioorg.2021.105206%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.bioorg.2021.105206%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445218%26amp%3Bitem_key%3DY9WP36VB%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Discovery%20of%20new%20anticancer%20thiourea-azetidine%20hybrids%3A%20design%2C%20synthesis%2C%20in%20vitro%20antiproliferative%2C%20SAR%2C%20in%20silico%20molecular%20docking%20against%20VEGFR-2%2C%20ADMET%2C%20toxicity%2C%20and%20DFT%20studies%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deepa%20R.%22%2C%22lastName%22%3A%22Parmar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jigar%20Y.%22%2C%22lastName%22%3A%22Soni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ramakrishna%22%2C%22lastName%22%3A%22Guduru%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rahul%20H.%22%2C%22lastName%22%3A%22Rayani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rakesh%20V.%22%2C%22lastName%22%3A%22Kusurkar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anand%20G.%22%2C%22lastName%22%3A%22Vala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sahista%20N.%22%2C%22lastName%22%3A%22Talukdar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ibrahim%20H.%22%2C%22lastName%22%3A%22Eissa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ahmed%20M.%22%2C%22lastName%22%3A%22Metwaly%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ahmed%22%2C%22lastName%22%3A%22Khalil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vishwanath%22%2C%22lastName%22%3A%22Zunjar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Satyanarayana%22%2C%22lastName%22%3A%22Battula%22%7D%5D%2C%22abstractNote%22%3A%22With%20the%20aim%20to%20discover%20potent%20and%20novel%20antitumor%20agents%2C%20a%20series%20of%20thiourea%20compounds%20bearing%203-%284-methoxyphenyl%29azetidine%20moiety%20were%20designed%20according%20to%20the%20essential%20pharmacophoric%20features%20of%20the%20reported%20VEGFR-2%20inhibitors%20and%20synthesized.%20All%20the%20synthesized%20compounds%20were%20evaluated%20for%20their%20in%20vitro%20anticancer%20activity%20against%20various%20human%20cancer%20cell%20lines%20%28lung%20%28A549%29%2C%20prostate%20%28PC3%29%2C%20breast%20%28MCF-7%29%2C%20liver%20%28HepG2%29%2C%20colon%20%28HCT-116%29%2C%20ovarian%20%28SKOV-3%29%2C%20skin%20%28A431%29%2C%20brain%20%28U251%29%20and%20kidney%20%28786-O%29%29.%203-%284-Methoxy-3-%282-methoxypyridin-4-yl%29phenyl%29-N-%284-methoxyphenyl%29azetidine-1-carbothioamide%20%283B%29%20was%20found%20to%20be%20most%20potent%20member%20against%20PC3%2C%20U251%2C%20A431%2C%20and%20786-O%20cancer%20cell%20lines%20with%20EC50%20values%200.25%2C%200.6%2C%200.03%2C%20and%200.03%5Cu00a0%5Cu00b5M%2C%20respectively%20and%20showed%20more%20potency%20than%20Doxorubicin%20in%20PC3%2C%20A431%2C%20and%20786-O%20cell%20lines.%20Compounds%201B%20to%207B%20showed%20EC50%20values%20ranging%20from%200.03%20to%2012.55%5Cu00a0%5Cu00b5M%20in%20A431%20cell%20line.%20Compound%203-%284-methoxy-3-%28pyridin-4-yl%29phenyl%29-N-%284-methoxyphenyl%29azetidine-1-carbothioamide%20%281B%29%20was%20found%20to%20be%20highly%20efficient%20in%20A431%20and%20786-O%20cell%20line%20with%20EC50%20values%20of%200.77%20and%200.73%5Cu00a0%5Cu00b5M%20respectively.%20All%20the%20compounds%20exhibited%20good%20to%20moderate%20cytotoxic%20activity.%20The%20pharmacophoric%20features%20and%20molecular%20docking%20studies%20confirmed%20the%20potentialities%20of%20compounds%201B%2C%202B%2C%203B%20and%205B%20to%20be%20VEGFR-2%20inhibitors.%20Moreover%2C%20in%20silico%20ADMET%20prediction%20indicated%20that%20most%20of%20the%20synthesized%20compounds%20have%20drug-like%20properties%2C%20possess%20low%20adverse%20effects%20and%20toxicity.%20In%20addition%2C%20the%20DFT%20studies%20for%20the%20most%20active%20compounds%20%281B%20and%203B%29%20were%20carried%20out.%20In%20the%20end%2C%20our%20studies%20revealed%20that%20the%20compounds%201B%20and%203B%20represent%20promising%20anticancer%20potentialities%20through%20their%20VEGFR-2%20inhibition.%22%2C%22date%22%3A%22October%201%2C%202021%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.bioorg.2021.105206%22%2C%22ISSN%22%3A%220045-2068%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0045206821005836%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-08-03T20%3A28%3A04Z%22%7D%7D%5D%7D
Parmar, D. R., Soni, J. Y., Guduru, R., Rayani, R. H., Kusurkar, R. V., Vala, A. G., Talukdar, S. N., Eissa, I. H., Metwaly, A. M., Khalil, A., Zunjar, V., & Battula, S. (2021). Discovery of new anticancer thiourea-azetidine hybrids: design, synthesis, in vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies. Bioorganic Chemistry, 115, 105206. https://doi.org/10.1016/j.bioorg.2021.105206 Cite
